Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

50%(1 trials)

Terminated

1(33%)

Phase Distribution

Ph not_applicable

33%

Ph phase_2

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

2(66.7%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(1)

Detailed Status

Completed2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 2

Trials by Phase

Phase 22 (66.7%)

N/A1 (33.3%)

Trials by Status

terminated133%

completed267%

Recent Activity

0 active trials

Showing 3 of 3

completednot_applicable

Alcohol, Inflammation, and Mindfulness Study (AIM)

NCT02994043

terminatedphase_2

Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1

NCT00249431

completedphase_2

Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence

NCT00218075

Clinical Trials (3)

Showing 3 of 3 trials

NCT02994043Not Applicable

Alcohol, Inflammation, and Mindfulness Study (AIM)

Completed

NCT00249431Phase 2

Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1

Terminated

NCT00218075Phase 2

Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence

Completed

All 3 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 3